Lamotrigine Tablets 25mg “AMEL” (Lamotrigine Tablets “AMEL”® / ラモトリギン錠25mg「アメル」)

JPY ¥1,900

Japanese antiepileptic agent / bipolar disorder treatment (Lamotrigine 25mg). Oral tablet for epilepsy monotherapy/adjunctive therapy and bipolar disorder mood episode relapse prevention. 140 tablets [14 tablets (PTP) x 10]. Mfd. by Kyowa Pharmaceutical Industry Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥1,748
10 - 19 12% JPY ¥1,672
20 + 18% JPY ¥1,558
SKU: LAM-25-TAB Category:

Description

Product Overview / 商品概要

Lamotrigine Tablets 25mg “AMEL” (ラモトリギン錠25mg「アメル」)
Generic: Lamotrigine / ラモトリギン
Therapeutic Category: Antiepileptic agent, Bipolar disorder treatment / 抗てんかん剤、双極性障害治療薬
Manufactured by: Kyowa Pharmaceutical Industry Co., Ltd. / 共和薬品工業株式会社

Composition & Specification / 組成・規格

Active Ingredient: Lamotrigine 25mg per tablet / 1錠中、ラモトリギン25mgを含有する。
Additives: Precipitated calcium carbonate, Low-substituted hydroxypropylcellulose, Magnesium aluminometasilicate, Povidone, Sodium starch glycolate, Acesulfame potassium, Sucralose, Flavoring, Magnesium stearate / 沈降炭酸カルシウム、低置換度ヒドロキシプロピルセルロース、ケイ酸マグネシウムアルミニウム、ポビドン、デンプングリコール酸ナトリウム、アセスルファムカリウム、スクラロース、香料、ステアリン酸マグネシウム
Appearance: Uncoated tablet, white, diameter: approx. 5.3mm, thickness: approx. 2.0mm, weight: approx. 63.3mg, identification code: 25 Lamotrigine Amel
外観: 素錠、白色、直径:約5.3mm、厚さ:約2.0mm、質量:約63.3mg、識別コード:25 ラモトリギン アメル

Indications / 効能効果

EN: Monotherapy for the following seizures in epileptic patients: partial seizures (including secondarily generalized seizures), tonic-clonic seizures, typical absence seizures. Adjunctive therapy with other antiepileptic drugs for the following seizures in epileptic patients with insufficient response: partial seizures (including secondarily generalized seizures), tonic-clonic seizures, generalized seizures in Lennox-Gastaut syndrome. Prevention of recurrence/relapse of mood episodes in bipolar disorder.
JA: ○てんかん患者の下記発作に対する単剤療法:部分発作(二次性全般化発作を含む)、強直間代発作、定型欠神発作 ○他の抗てんかん薬で十分な効果が認められないてんかん患者の下記発作に対する抗てんかん薬との併用療法:部分発作(二次性全般化発作を含む)、強直間代発作、Lennox-Gastaut症候群における全般発作 ○双極性障害における気分エピソードの再発・再燃抑制

Dosage and Administration / 用法用量

EN: For epilepsy (adults): Monotherapy (partial seizures and tonic-clonic seizures): Weeks 1-2: 25mg once daily; Weeks 3-4: 50mg once daily; Week 5: 100mg once or twice daily; thereafter increase by up to 100mg every 1-2 weeks. Maintenance: 100-200mg/day (max 400mg/day). With valproate sodium: Weeks 1-2: 25mg every other day; Weeks 3-4: 25mg once daily; thereafter increase by 25-50mg every 1-2 weeks. Maintenance: 100-200mg/day in 2 divided doses. Without valproate (with glucuronidation inducers): Weeks 1-2: 50mg once daily; Weeks 3-4: 100mg in 2 divided doses; thereafter increase by up to 100mg every 1-2 weeks. Maintenance: 200-400mg/day in 2 divided doses. For bipolar disorder (adults): Monotherapy: Weeks 1-2: 25mg once daily; Weeks 3-4: 50mg once or twice daily; Week 5: 100mg; Week 6 onwards: maintenance 200mg/day once or twice daily (max 400mg/day). With valproate: Weeks 1-2: 25mg every other day; Weeks 3-4: 25mg once daily; Week 5: 50mg; Week 6 onwards: maintenance 100mg/day (max 200mg/day).
JA: てんかん患者に用いる場合(成人):単剤療法の場合(部分発作及び強直間代発作):最初の2週間は1日25mgを1日1回、次の2週間は1日50mgを1日1回、5週目は1日100mgを1日1回又は2回、その後1〜2週間毎に最大100mgずつ漸増。維持用量は1日100〜200mg(最大400mg)。バルプロ酸ナトリウム併用:最初の2週間は1回25mgを隔日、次の2週間は1日25mgを1日1回、その後1〜2週間毎に25〜50mgずつ漸増。維持用量は1日100〜200mgを1日2回。バルプロ酸ナトリウムを併用しない場合(グルクロン酸抱合誘導薬剤を併用):最初の2週間は1日50mgを1日1回、次の2週間は1日100mgを1日2回、その後最大100mgずつ漸増。維持用量は1日200〜400mgを1日2回。双極性障害における気分エピソードの再発・再燃抑制(成人):単剤療法:最初の2週間は1日25mgを1日1回、次の2週間は1日50mgを1日1回又は2回、5週目は1日100mg、6週目以降は維持用量として1日200mgを1日1回又は2回(最大400mg)。バルプロ酸ナトリウム併用:最初の2週間は1回25mgを隔日、次の2週間は1日25mgを1日1回、5週目は1日50mg、6週目以降は維持用量として1日100mg(最大200mg)。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 23000AMX00328
Sales Started: June 2018 / 2018年6月
Classification Code: 871139
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 140 tablets [14 tablets (PTP) x 10] / 140錠[14錠(PTP)×10]
Other Available Packages (by special order): 140 tablets [14 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Lamotrigine Tablets 25mg “AMEL” (Lamotrigine Tablets “AMEL”® / ラモトリギン錠25mg「アメル」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Lamotrigine Tablets 25mg "AMEL" (Lamotrigine Tablets "AMEL"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.